Status:
ACTIVE_NOT_RECRUITING
Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)
Lead Sponsor:
University of Minnesota
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
This is a mixed-methods study that includes three steps. The first is a focus group to collect opinions and feedback about implementation of aTMS among clinicians, technicians, nurses, and other clini...
Eligibility Criteria
Inclusion
- Age between 18 and 70 years old
- Current patient of SLP Clinic
- Diagnosis of Unipolar Depression
- Have tried at least 1 antidepressant
- Ability to maintain stable medication regimen for duration of study
Exclusion
- Has received TMS in the last 3 months
- Diagnosis of Bipolar Depression
- Any lifetime psychosis or mania
- Recent suicide attempt within 90 days of study visit
- Use of Benzodiazepines in past 4 weeks
- Presence of any contraindication to TMS assessed by the TMS Adult Safety Screen including individual history of uncontrolled seizures
- Current or history of alcohol abuse
Key Trial Info
Start Date :
June 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06961851
Start Date
June 9 2025
End Date
June 1 2026
Last Update
November 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455